Performance analysis of ABVC BioPharma (ABVC)
Annual Return
Over the past 3 years, ABVC has had an average annual return of -31.39%, underperforming the benchmark SPY, which returned +19.63% annual.
Over the past 5 years, ABVC has had an average annual return of -52.36%, underperforming the benchmark SPY, which returned +12.73% annual.
Over the past 10 years, ABVC has had an average annual return of -43.35%, underperforming the benchmark SPY, which returned +15.04% annual.
Since Apr 5, 2011, ABVC has had an average annual return of -12.30%, underperforming the benchmark SPY, which returned +13.93% annual.
| 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| -42.25% | +261.12% | -49.17% | -81.44% | -81.56% | -33.53% | +16.70% | -87.86% | -0% | +0% | -74.88% | +249,899.04% |
| 2014 | 2013 | 2012 | 2011 | ||||||||
| +0% | +88.82% | -94.12% | -43.75% |
Monthly Return
| Year | Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Annually Total |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026 | -5.17% | -35.15% | -25.91% | +6.14% | +36.87% | +12.10% | -22.17% | -42.25% | |||||
| 2025 | -12.29% | +33.33% | +53.72% | -0% | +29.24% | +62.38% | +7.87% | +17.88% | +7.42% | -7.88% | -3.21% | -21.42% | +261.12% |
| 2024 | +30.99% | -20.40% | +8.26% | -4.55% | -36.46% | -2.54% | +0.71% | -13.41% | +1.22% | +1.07% | -23.24% | +11.25% | -49.17% |
| 2023 | +15.44% | -7.97% | -3.61% | +6.25% | +0.01% | -23.61% | -52.07% | -47.40% | -20.59% | +3.79% | +16.74% | -7.93% | -81.44% |
| 2022 | -26.25% | -0.80% | +10.08% | -12.45% | -17.16% | -46.46% | -38.68% | +55.38% | -12.88% | -17.04% | +1.19% | -15.40% | -81.56% |
| 2021 | -1.96% | -16.40% | +7.66% | -0% | +22.22% | -8.18% | -2.18% | -41.30% | -20.35% | +9.96% | +19.68% | +11.51% | -33.53% |
| 2020 | -33.64% | +0% | -15.52% | +30.61% | -6.25% | +0% | +31.67% | +1.27% | +0% | -2.50% | +7.69% | +21.43% | +16.70% |
| 2019 | -25.00% | -3.33% | +3.45% | -16.67% | -4.44% | -39.53% | -15.38% | -25.73% | +10.16% | -41.11% | +25.47% | -34.29% | -87.86% |
| 2018 | +0% | +0% | +0% | +0% | -5.00% | +0% | +0% | +5.26% | -17.50% | +0% | -3.03% | +25% | -0% |
| 2017 | +0% | +0% | +0% | +0% | +0% | +0% | +0% | +0% | +0% | +0% | +0% | +0% | +0% |
Drawdown analysis of ABVC BioPharma (ABVC)
The maximum drawdown for the ABVC was -99.97%, occurring on Feb 13, 2025. This drawdown has not yet recovered.
The current ABVC drawdown is -99.92%.
Since Apr 5, 2011 ABVC has experienced the following drawdowns:
- 50% or more: 4 times
- 40% or more: 4 times
- 30% or more: 4 times
- 20% or more: 4 times
- 10% or more: 4 times
| Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -99.97% | Aug 24, 2015 | 2383 | Feb 13, 2025 | Ongoing | Ongoing | Ongoing |
| -99.81% | Aug 26, 2011 | 572 | Dec 5, 2013 | 431 | Aug 24, 2015 | 1003 |
| -89.75% | Apr 21, 2011 | 61 | Jul 20, 2011 | 15 | Aug 10, 2011 | 76 |
| -62.50% | Aug 17, 2011 | 1 | Aug 18, 2011 | 6 | Aug 26, 2011 | 7 |